Cramer: Biogen's Alzheimer's treatment would be 'the biggest drug ever'

Biogen is planning to file for U.S. regulatory approval for its Alzheimer's treatment after fresh analysis of its clinical trial showed promise, the drugmaker said. CNBC's "Squawk on the Street" crew discuss the implication of the drug.
Tue, Oct 22 20199:35 AM EST